NCT06066476View on ClinicalTrials.gov

Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease

CompletedOBSERVATIONAL
Enrollment

1,022

Participants

Timeline

Start Date

June 24, 2017

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Coronary Artery Disease
Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Genoss Co., Ltd.

INDUSTRY

NCT06066476 - Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease | Biotech Hunter | Biotech Hunter